Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Ullrich congenital muscular dystrophy: clinical case study

View through CrossRef
Introduction. Ullrich congenital muscular dystrophy (Ullrich СMD, OMIM #254090) is the most severe form of skeletal muscle collagenopathy associated with three genes (COL6A1, COL6A2, COL6A3). The purpose of the report was to present our own observation of clinical cases with Ullrich congenital muscular dystrophy in two unrelated Yakut families. Materials and methods. A clinical and genealogical examination, electroneuromyography, muscle MRI, muscle biopsy, and molecular genetic research using the massively parallel sequencing method were carried out. Results. The cause of the disease in the first family was two mutations in a compound heterozygous state: c.1561C>T and c.2329T>C in the COL6A2 gene; in the second family, the c.2329T>C mutation in the COL6A2 gene in a homozygous state. The clinical picture of the disease was manifested by muscle weakness and hypotonia, hypermobility of the interphalangeal joints, contractures of the elbow, ankle and knee joints, delayed motor development, spinal deformity, and skin changes. The type of inheritance in families is autosomal recessive. Conclusions. Despite the rarity of the disease, neurologists and geneticists, when identifying symptoms of myopathy, delayed motor development, and the presence of hypermobility in the distal joints, contrasting with retractions of the proximal and axial joints, must be alert to Ullrich CMD. Next-generation sequencing techniques make it easier to diagnose the disease. Keywords: congenital muscular dystrophy, Ullrich's disease, COL6A2, Yakut family, clinical case.
Title: Ullrich congenital muscular dystrophy: clinical case study
Description:
Introduction.
Ullrich congenital muscular dystrophy (Ullrich СMD, OMIM #254090) is the most severe form of skeletal muscle collagenopathy associated with three genes (COL6A1, COL6A2, COL6A3).
The purpose of the report was to present our own observation of clinical cases with Ullrich congenital muscular dystrophy in two unrelated Yakut families.
Materials and methods.
A clinical and genealogical examination, electroneuromyography, muscle MRI, muscle biopsy, and molecular genetic research using the massively parallel sequencing method were carried out.
Results.
The cause of the disease in the first family was two mutations in a compound heterozygous state: c.
1561C>T and c.
2329T>C in the COL6A2 gene; in the second family, the c.
2329T>C mutation in the COL6A2 gene in a homozygous state.
The clinical picture of the disease was manifested by muscle weakness and hypotonia, hypermobility of the interphalangeal joints, contractures of the elbow, ankle and knee joints, delayed motor development, spinal deformity, and skin changes.
The type of inheritance in families is autosomal recessive.
Conclusions.
Despite the rarity of the disease, neurologists and geneticists, when identifying symptoms of myopathy, delayed motor development, and the presence of hypermobility in the distal joints, contrasting with retractions of the proximal and axial joints, must be alert to Ullrich CMD.
Next-generation sequencing techniques make it easier to diagnose the disease.
Keywords: congenital muscular dystrophy, Ullrich's disease, COL6A2, Yakut family, clinical case.

Related Results

Diagnostic strategies for muscular dystrophies: a cross-sectional study
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Background Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians to perform an adequate diagnosis. Ma...
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Background: Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians  to perform an ...
Challenges in developing gene therapy against Duchenne muscular dystrophy
Challenges in developing gene therapy against Duchenne muscular dystrophy
Duchenne muscular dystrophy is a progressive X-linked recessive neuromuscular disorder resulting from pathogenic mutations in the DMD gene, which codes dystrophin. It is one of the...
COL6A1 related muscular dystrophy in Landseer dogs: A canine model for Ullrich congenital muscular dystrophy
COL6A1 related muscular dystrophy in Landseer dogs: A canine model for Ullrich congenital muscular dystrophy
AbstractBackgroundCollagen VI related myopathies are congenital diseases of variable phenotype. The severe phenotype is referred to as Ullrich congenital muscular dystrophy. In thi...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy
A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy
Abstract A novel canine muscular dystrophy in Landseer dogs was observed. We had access to five affected dogs from two litters. The clinical signs started at a few w...
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
Background Cardiomyopathy is a leading cause of mortality among Duchenne muscular dystrophy patients and lacks effective therapies. Phosphodiesterase type 5 is ...
Advanced Physiotherapy Intervention for Muscular Dystrophy
Advanced Physiotherapy Intervention for Muscular Dystrophy
Muscular dystrophies are rare neuromuscular conditions which are genetically and clinically diverse that cause gradual, progressive weakness and breakdown of skeletal muscles over ...

Back to Top